Christopher J. Endres

Author

Also Known As

C J Endres, C. Endres, C. J. Endres, C.J. Endres, CHRISTOPHER J. ENDRES, Christopher Endres, Christopher J Endres, Christopher J. ENDRES, Christopher J. Endres, Christopher James ENDRES

Publications

3.6K

Citations

H-Index

116

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine University of Washington University of Wisconsin–Madison Seagen (United States)

About

Christopher J. Endres is an author at Johns Hopkins University specializing in medicine, pharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	26	1.3K
2	Health Sciences	10	10	765
3	Engineering	4	4	379
4	Natural Sciences	3	3	149
5	Public Health	1	1	36

Christopher J. Endres

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Biodistribution, Tumor Detection, and Radiation Dosimetry of <sup>18</sup>F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer Steve Y. Cho, Kenneth L. Gage, Ronnie C. Mease, Journal of Nuclear Medicine	2012	277
Kinetic Modeling in Positron Emission Tomography Evan D. Morris, Christopher J. Endres, Kathleen Schmidt, Elsevier eBooks Positron Emission TomographyComputed TomographyEngineeringMedical ImagingPhysics	2004	211
Kinetic Modeling of [<sup>11</sup>C]Raclopride: Combined PET-Microdialysis Studies Christopher J. Endres, Bhaskar Kolachana, Richard C. Saunders, Journal of Cerebral Blood Flow & Metabolism PsychopharmacologyChemistryExperimental PharmacologySocial SciencesDopamine Release	1997	193
The role of transporters in drug interactions Christopher J. Endres, Peng Hsiao, Jashvant D. Unadkat European Journal of Pharmaceutical Sciences	2005	177
Imaging Brain Mu-Opioid Receptors in Abstinent Cocaine Users: Time Course and Relation to Cocaine Craving David A. Gorelick, Yu Kyeong Kim, Badreddine Bencherif, Biological Psychiatry Substance AbuseSubstance UseBehavioral NeuroscienceAddictionBrain Mu-opioid Receptors	2005	166
Quantitative Prediction of Human Pharmacokinetics for Monoclonal Antibodies Jennifer Dong, David H. Salinger, Christopher J. Endres, Clinical Pharmacokinetics Translational MedicineMedicineBiostatisticsQuantitative PredictionPharmacology	2011	153
Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model Yun Zhou, Christopher J. Endres, James Robert Brašić, NeuroImage Positron Emission TomographyEngineeringMedical ImagingPet-mriAdvanced Imaging	2003	135
Initial Evaluation of <sup>11</sup>C-DPA-713, a Novel TSPO PET Ligand, in Humans Christopher J. Endres, Martin G. Pomper, Michelle L. James, Journal of Nuclear Medicine	2009	127
Imaging glial cell activation with [<sup>11</sup>C]-<i>R</i>-PK11195 in patients with AIDS Dima A. Hammoud, Christopher J. Endres, Ankit Chander, Journal of NeuroVirology Primary ImmunodeficiencyGlial Cell ActivationMedicineImmunodeficienciesHuman Retrovirus	2005	111
Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2) Andrew G. Horti, Yongjun Gao, Hayden T. Ravert, Bioorganic & Medicinal Chemistry Positron Emission TomographyCannabis UseNuclear MedicineBiochemistryPet Imaging	2010	104

Page 1